15-Deoxy-Δ12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms

被引:42
作者
Bernardo, A [1 ]
Ajmone-Cat, MA [1 ]
Levi, G [1 ]
Minghetti, L [1 ]
机构
[1] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy
关键词
apoptosis; inflammation; microglia; peroxisome proliferator-activated receptor; prostaglandin;
D O I
10.1046/j.1471-4159.2003.02045.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have previously reported that rat primary microglial cultures express the nuclear receptor peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and that several functions associated with the activation of these cells, including nitric oxide (NO) and tumor necrosis factor-alpha synthesis, are down-regulated by 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) and ciglitazone, two specific PPAR-gamma agonists. Here we demonstrate that microglial cells not only express a functionally active PPAR-gamma, but also synthesize large amounts of 15d-PGJ(2) upon stimulation with lipopolysaccharide (LPS). In addition, we show that, although 15d-PGJ(2) and ciglitazone were equally effective in reducing microglial activation when used at 1-5 mum concentrations, 15d-PGJ(2), but not of ciglitazone, reduced PGE(2) production at low concentration (0.1 mum) and induced a time-dependent microglial impairment and apoptosis at high concentration (10 mum). Interestingly, the inhibition of PGE(2) production was achieved mainly through the inhibition of cycloxygenase-2 enzymatic activity, as the expression of this enzyme and that of the microsomal isoform of PGE synthase remained unaltered. These findings suggest that 15d-PGJ(2) affects the functional state and the survival of activated microglia through mechanisms only in part dependent on PPAR-gamma and that the concentration of 15d-PGJ(2) is crucial in determining the particular microglial function affected.
引用
收藏
页码:742 / 751
页数:10
相关论文
共 52 条
[1]   Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro [J].
Agresti, C ;
DUrso, D ;
Levi, G .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (06) :1106-1116
[2]   Role of the peroxisome proliferator-activated receptor-γ (PPAR-γ) and its natural ligand 15-deoxy-Δ12,14-prostaglandin J2 in the regulation of microglial functions [J].
Bernardo, A ;
Levi, G ;
Minghetti, L .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (07) :2215-2223
[3]   Bisphenol A diglycidyl ether (BADGE) is a PPARγ agonist in an ECV304 cell line [J].
Bishop-Bailey, D ;
Hla, T ;
Warner, TD .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (04) :651-654
[4]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[5]   Treatment of hydrops fetalis with hemofiltration [J].
Castillo, F ;
Nieto, J ;
Salcedo, S ;
Peguero, G ;
Castello, F .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :14-16
[6]   TNFα downregulates PPARδ expression in oligodendrocyte progenitor cells:: Implications for demyelinating diseases [J].
Cimini, A ;
Bernardo, A ;
Cifone, G ;
Di Muzio, L ;
Di Loreto, S .
GLIA, 2003, 41 (01) :3-14
[7]   Inflammatory mechanisms in Alzheimer's disease:: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists [J].
Combs, CK ;
Johnson, DE ;
Karlo, JC ;
Cannady, SB ;
Landreth, GE .
JOURNAL OF NEUROSCIENCE, 2000, 20 (02) :558-567
[8]   Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes [J].
Cristiano, L ;
Bernardo, A ;
Cerù, MP .
JOURNAL OF NEUROCYTOLOGY, 2001, 30 (08) :671-683
[9]  
Cullingford TE, 1998, J NEUROCHEM, V70, P1366
[10]   Emerging roles of PPARs in inflammation and immunity [J].
Daynes, RA ;
Jones, DC .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (10) :748-759